We are delighted to announce that our esteemed CSO, Dr. Zahra Dantes, has been invited to speak at the LSCCB symposium as a distinguished guest. The focus of the talk will be the “Onco-PDO Test Utilizing Patient-Derived Organoids (PDOs) in Supporting Next-Generation Precision Oncology for Cancer Patients“. We are proud that our cutting-edge technology and …
Register & attend our CME Event on 17th May 2023, online via Zoom, featuring Dr Rafael Rosell, Dr Zahra Dantes and Dr Darren Poon. Click this Link to register, or scan the QR code below. Dr. Rafael Rosell; 7pm – 7:20pm; 17th May 2023 Topic : Therapeutic Strategies for Oncogenic KRAS Non-Small Cell Lung Cancer …
The two research institutes in this collaboration are both located in the Hong Kong Science Park, including the LSCCB funded by the Innovation and Technology Commission’s Health@InnoHK innovation platform, and the Hong Kong Science and Technology Park Corporation partner company Invitrocue (Hong Kong). Read More (English)Read More (Traditional Chinese)Read More (Simplified Chinese) This event has …
Link to PDF (annalsofoncology.org) 233P – Breast Cancer Organoids Mimic Disease Heterogeneity, Allow High-Throughput Drug Screening and Show Correlation with Clinical Response Abstract 233P Background Breast cancer (BC) is a highly heterogeneous disease; therefore, it is urgent to identify an ex vivo model that accurately mimics the heterogeneity. Patient-derived organoids (PDOs) represent an ideal preclinical model …
Invitrocue Chief Scientific Officer, Dr. Zahra Dantes, will be presenting our latest findings on our current validation study regarding breast cancer at ESMO Breast Cancer 2022, 3-5 May, in Berlin. “Breast Cancer Organoids Mimic Disease Heterogeneity, Allow High-Throughput Drug Screening, and Show Correlation with Clinical Response” #202, Wednesday, 4 May, from 12:15 to 13:00 CEST. …
Date: 19th to 20th November 2020 Venue: Online Symposium Invitrocue is a participant in this Online Symposium. In this very challenging year for healthcare as a whole, the Oncoclínicas Group invites you to participate in an important continuing medical education initiative: the 8th Oncoclínicas International Symposium. The event will take place on the 19th and 20th of November, …
The drug discovery ecosystem is changing rapidly. The rise of robotics and AI enables the emergence of a new model of data-driven drug discovery. Bringing together recent advances in life sciences automation and machine learning applications for drug discovery, new partnerships evolve that allow for game-changing improvements in the drug discovery process. The webinar will …
[:en]Date: 14th to 15th November Venue: The Waldorf Hilton, Aldwych, London, UK Attendees: Martin Dieter Bach, Dr Andreas Lindner The two-day event, comprising company presentations, Q&A breakout sessions, workshops and thematic panels, will cover some of the most relevant and important issues facing the global Healthcare industry today, and serve as the leading European healthcare forum for healthcare executives and …
[:en]Date: 2nd November at 11.30am Venue: One Farrer Hotel, 1 Farrer Park Station Road, Singapore 217562 Dr Steven Fang will be speaking about “Strategic Investments in R/D to Accelerate Global Growth of Biotechnology Companies” detailing the following: Investment opportunities and partnerships in the Chronic disease segment Unique and advanced technologies showcase Expanding plan in Asia Co Located …